Bruno S.; Ghelli Luserna di Rora A.; Napolitano R.; Soverini S.; Martinelli G.; Simonetti G., CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies, «JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH», 2022, 41, Article number: 159 , pp. 1 - 16 [Scientific article]Open Access
de Santis S.; Monaldi C.; Martelli M.; Mancini M.; Bruno S.; Castagnetti F.; Gugliotta G.; Polakova K.M.; Ernst T.; Maar D.; Corner A.; Cavo M.; Soverini S., CML-184 A Novel Droplet Digital PCR Strategy for Rapid and Sensitive Detection of BCR::ABL1 Kinase Domain Mutations Conferring Resistance to Second-Generation Tyrosine Kinase Inhibitors, «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2022, 22, pp. 289 - 290 [Scientific article]
Mancini M.; Monaldi C.; De Santis S.; Rondoni M.; Papayannidis C.; Sartor C.; Curti A.; Bruno S.; Cavo M.; Soverini S., Combined Inhibition of Polo-like Kinase-1 and Wee1 as a New Therapeutic Strategy to Induce Apoptotic Cell Death in Neoplastic Mast Cells, «CANCERS», 2022, 14, pp. 738 - 750 [Scientific article]Open Access
Soverini, S.; De Santis, S.; Martelli, M.; Monaldi, C.; Castagnetti, F.; Gugliotta, G.; Papayannidis, C.; Mancini, M.; Bruno, S.; Venturi, C.; Machova Polakova, K.; Ernst, T.; Maar, D.; Corner, A.; Cavo, M., Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemia, «LEUKEMIA», 2022, 36, pp. 2250 - 2260 [Scientific article]
Monaldi C.; de Santis S.; Mancini M.; Papayannidis C.; Sartor C.; Rondoni M.; Bruno S.; Cavo M.; Soverini S., MPN-182 Droplet Digital PCR for Non-Invasive Detection of the KIT D816V Mutation in the Peripheral Blood of Patients With Suspected Systemic Mastocytosis, «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2022, 22, pp. S328 - S328 [Scientific article]
De Santis, S.; Monaldi, C.; Mancini, M.; Bruno, S.; Cavo, M.; Soverini, S., Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid Leukemia, «ONCOTARGETS AND THERAPY», 2022, 15, pp. 103 - 116 [Scientific article]Open Access
Mancini M.; De Santis S.; Monaldi C.; Castagnetti F.; Lonetti A.; Bruno S.; Dan E.; Sinigaglia B.; Rosti G.; Cavo M.; Gugliotta G.; Soverini S., Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors, «FRONTIERS IN ONCOLOGY», 2022, 12, Article number: 901132 , pp. 1 - 13 [Scientific article]Open Access
Baccarani M.; Bonifazi F.; Soverini S.; Castagnetti F.; Gugliotta G.; Saber W.; Estrada-Merly N.; Rosti G.; Gale R.P., Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia, «LEUKEMIA», 2022, 36, pp. 1227 - 1236 [Scientific article]Open Access
Gugliotta G.; Castagnetti F.; Breccia M.; Levato L.; Intermesoli T.; D'Adda M.; Salvucci M.; Stagno F.; Rege-Cambrin G.; Tiribelli M.; Martino B.; Bocchia M.; Cedrone M.; Trabacchi E.; Cavazzini F.; Porretto F.; Sora F.; Simula M.P.; Albano F.; Soverini S.; Foa R.; Pane F.; Cavo M.; Saglio G.; Baccarani M.; Rosti G., Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 study, «HAEMATOLOGICA», 2022, 107, pp. 2356 - 2364 [Scientific article]Open Access
Schafer, V.; White, H. E.; Gerrard, G.; Mobius, S.; Saussele, S.; Franke, G. -N.; Mahon, F. -X.; Talmaci, R.; Colomer, D.; Soverini, S.; Machova Polakova, K.; Cross, N. C. P.; Hochhaus, A.; Ernst, T., Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network, «JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY», 2021, 147, pp. 3081 - 3089 [Scientific article]Open Access
Soverini, S.; Martelli, M.; Bavaro, L.; De Benedittis, C.; Sica, S.; Sora, F.; Iurlo, A.; Bonifacio, M.; Pregno, P.; Galimberti, S.; Lunghi, F.; Albano, F.; D'Adda, M.; Crugnola, M.; Capodanno, I.; Castagnetti, F.; Gugliotta, G.; Papayannidis, C.; Rosti, G.; Percesepe, A.; Mignone, F.; Baccarani, M.; Martinelli, G.; Cavo, M., BCR-ABL1 compound mutants: prevalence, spectrum and correlation with tyrosine kinase inhibitor resistance in a consecutive series of Philadelphia chromosome-positive leukemia patients analyzed by NGS, «LEUKEMIA», 2021, 35, pp. 2102 - 2107 [Scientific article]
Bruno S.; Bandini L.; Patuelli A.; Robustelli V.; Venturi C.; Mancini M.; Forte D.; De Santis S.; Monaldi C.; Grassi A.; Chiurumbolo G.; Paolini S.; Cristiano G.; Papayannidis C.; Sartor C.; Nanni J.; Ottaviani E.; Curti A.; Cavo M.; Soverini S., Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia, «FRONTIERS IN ONCOLOGY», 2021, 11, Article number: 728613 , pp. 728613 - 728619 [Scientific article]Open Access
Martinelli, Giovanni; Papayannidis, Cristina; Piciocchi, Alfonso; Robustelli, Valentina; Soverini, Simona; Terragna, Carolina; Marconi, Giovanni; Lemoli, Roberto Massimo; Guolo, Fabio; Fornaro, Antonella; Lunghi, Monia; de Fabritiis, Paolo; Candoni, Anna; Selleri, Carmine; Simonetti, Federico; Bocchia, Monica; Vitale, Antonella; Frison, Luca; Tedeschi, Alessandra; Cuneo, Antonio; Bonifacio, Massimiliano; Martelli, Maria Paola; D'Ardia, Stefano; Trappolini, Silvia; Tosi, Patrizia; Galieni, Piero; Fabbiano, Francesco; Abbenante, Maria Chiara; Granier, Muriel; Zhu, Zhaoyin; Wang, Mingyue; Sartor, Chiara; Paolini, Stefania; Cavo, Michele; Foà, Robin; Fazi, Paola; Vignetti, Marco; Baccarani, Michele, INCB84344-201: Ponatinib and steroids in frontline therapy of unfit patients with Ph+ acute lymphoblastic leukemia, «BLOOD ADVANCES», 2021, 6, pp. 1742 - 1753 [Scientific article]Open Access
Soverini S., Review of: Improving prognostication and management of systemic mastocytosis, «THE LANCET. HAEMATOLOGY», 2021, 8, pp. e164 - e166 [Review]
Papayannidis C.; Sartor C.; Dominietto A.; Zappone E.; Arpinati M.; Marconi G.; Cristiano G.; Nanni J.; Parisi S.; Barbato F.; Paolini S.; Soverini S.; Terragna C.; Robustelli V.; Testoni N.; Chirumbolo G.; Curti A.; Cavo M.; Bonifazi F., Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant, «HEMATOLOGICAL ONCOLOGY», 2021, 39, pp. 580 - 583 [Scientific article]
